WO2014130801A1 - Administration entérique d'ingrédients fonctionnels pour animaux - Google Patents

Administration entérique d'ingrédients fonctionnels pour animaux Download PDF

Info

Publication number
WO2014130801A1
WO2014130801A1 PCT/US2014/017656 US2014017656W WO2014130801A1 WO 2014130801 A1 WO2014130801 A1 WO 2014130801A1 US 2014017656 W US2014017656 W US 2014017656W WO 2014130801 A1 WO2014130801 A1 WO 2014130801A1
Authority
WO
WIPO (PCT)
Prior art keywords
coating
composition
microencapsulated
enteric
functional ingredient
Prior art date
Application number
PCT/US2014/017656
Other languages
English (en)
Inventor
Ahmad Akashe
Fu-I Mei
Robert L. Magaletta
Anilkumar Ganapati Gaonkar
Original Assignee
Intercontinental Great Brands Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercontinental Great Brands Llc filed Critical Intercontinental Great Brands Llc
Publication of WO2014130801A1 publication Critical patent/WO2014130801A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A23K40/35—Making capsules specially adapted for ruminants

Definitions

  • the present application relates to microencapsulated materials for consumption by animals. More particularly, the microencapsulated materials include functional ingredients in an enteric matrix effective for delivering the function ingredients to farm and domestic animals, including ruminant animals.
  • Enteric delivery of functional materials in food and feed applications has been limited. Enteric delivery systems are commonly utilized when the functional materials or medicaments are known to be sensitive to certain conditions such that they become less effective or if the functional materials cause problems during consumption, such as stomach problems with aspirin. Further, enteric delivery systems are commonly utilized when the functional materials or medicaments are known to be sensitive or unstable at low pH or in ruminant conditions or have undesirable flavor and / or taste characteristics which cannot be effectively masked by other methods.
  • enteric delivery is accomplished by coating tablets and gel capsules.
  • those particular delivery methods are not well suited for food or animal feed-type applications.
  • neither tablets nor capsules are sized to be integrated into most existing food or animal feed-type products.
  • microencapsulation An alternative process for enteric delivery is microencapsulation.
  • one issue with microencapsulation is the recovery rate, or microencapsulation efficiency of the process.
  • the uncaptured material may be recovered for reuse, recycled, or a percentage of the uncaptured material remains adhered to the outer surface of the microencapsulated particulates.
  • the product tends to have a taste profile associated with the uncaptured material, which is often undesirable. This is particularly true when the uncaptured material includes oxidizable triglycerides such as unsaturated and
  • functional ingredients such as essential oils
  • one limitation of incorporating essential oils into foods, beverages, and animal feed is their strong, pungent smell and taste.
  • ruminant animals introduce further complexity due to the different chewing and digestive process in such animals. Ruminant animals generally chew feedstuff to tear and increase the surface area of the feed which helps to break down the feed during digestion. For example, ruminant animals, such as cows, often move their flat teeth side to side to tear the feed into a pulp. Therefore, enteric materials need to be sized such that they do not substantially break down during chewing. Ruminant animals also digest food/ feed differently from domestic animals and humans.
  • ruminant animals have four ruminant sacks where feed, plant material and the like is digested by fermentation of cellulosic material by microorganisms such as conversion of carbohydrates into volatile fatty acids and gases. This process allows the ruminant animal to convert cellulosic fiber into energy.
  • ruminant animals also regurgitate boluses of non-digested material (cud) for re-mastication.
  • Boluses tend to float on top in the ruminant fluid in one of the ruminant sacks. Therefore, if the enteric material is included in the boluses, they are susceptible to re-mastication, thereby increasing the risk that the materials will break down prior to reaching the desired location in the digestive tract during repetitive chewing processes.
  • Ruminants also produce large amount of saliva.
  • Saliva in ruminant animals serves two functions, buffering and suppressing foam.
  • Saliva in ruminants typically has a pH value of approximately 8.2 and a high sodium bicarbonate level. This means that the saliva helps to counteract the effects of acid-producing feedstuffs, such as cereals, molasses, potatoes and fodder beets, on the ruminal pH (rumen's pH is typically 5.5-7.0 depending on the feed). Further, saliva helps to suppress the foaming effect in the rumen.
  • the feed particles become smaller as the bacteria work and the rumination process continues.
  • the feed particles gradually absorb fluid and sink to the bottom of the rumen.
  • the contents in the bottom of the reticulo-rumen or the first and second of four chambers in the animal generally has a dry matter content of 5%.
  • the rumen generally contracts about once or twice every minute or so, such as with cows. The contractions allow mixing of fluid and solid contents in the rumen to stimulate fermentation and avoid stagnation. Contractions also serve to release gases trapped in either the mat or fluid portion of the rumen. The fermentation gases are then released by belching.
  • Feed particles of the correct size and density are segregated into the fluid in the reticulum by the ruminal contractions. Subsequent contractions force these particles and some of the fluid contents out of the reticulo-rumen and into the omasum or the third of four chambers in a ruminant's stomach.
  • the rumen and reticulum are basically one compartment, but with different functions. While much of fermentative action occurs in the rumen (first chamber), the reticulum (second chamber) serves as a staging area for passage into the omasum or regurgitation.
  • the omasum is the third compartment of the ruminant animal's stomach. It is characterized by the presence of a large number of leaves, which provide a wide absorption surface (about 4-5 m 2 ). This surface absorbs water (30-60% of the water intake) and nutrients such as potassium and sodium. The omasum also prevents the passage of large particles through the digestive system.
  • the abomasum is believed to be the equivalent of human stomach, having an acidic pH (2-3), where proteins are broken down. True digestion finally occurs in the fourth stomach.
  • the abomasum glands produce hydrochloric acid, pepsin and lipase which break down the food into all its constituent nutrients.
  • the feed When the feed has passed through the acid abomasum it enters the small intestine.
  • the pH value increases because the feed is mixed with bile and pancreatic secretions, with a pH value of 8.
  • the main functions of small intestine are to enzymatically break down nutrients so that they can be absorbed and absorb nutrients (i.e., fatty acids, sugars, and amino acids) and water via the intestinal villi.
  • Microencapsulated materials and methods of manufacturing are provided that are suitable for animals, including ruminant animals, while still providing acceptable enteric delivery properties in view of the complex digestive process in animals.
  • functional ingredients such as essential oils may be microencapsulated into an enteric matrix suitable for animal digestion and, in particular, ruminant digestion.
  • a coating of an enteric material may be applied.
  • the microencapsulated materials may also be coated with a coating or layer that has a solubility less than about 20% at a pH of about 5.5 or greater.
  • a microencapsulated composition for use with animal feed includes a functional ingredient composition, an enteric material coating the functional ingredient composition, and an outer coating having a solubility less than about 20% at a pH of about 5.5 or greater.
  • a microencapsulated composition for use with animal feed includes a granulated core and an outer coating.
  • the granulated core includes a plurality of particles in combination with a granulating material.
  • the particles include a functional ingredient composition microencapsulated in an enteric material.
  • the outer coating at least substantially surrounds the granulated core and has a solubility less than about 20% at a pH of about 5.5 or greater.
  • an animal feed composition includes a feed material, a functional ingredient composition, an enteric coating and an outer coating.
  • the feed material includes an interior and an exterior and is selected from the group consisting of grains, cereals, legumes, wheat, soy, rice and combinations thereof.
  • the functional ingredient composition is located on the interior of the feed material.
  • the enteric coating covers at least one of the functional ingredient composition and the feed material.
  • the outer coating has a solubility less than about 20% at a pH of about 5.5 or greater and is located on the exterior of the feed material.
  • the enteric material coating is selected from the group consisting of zein, caseinate, shellac and combinations thereof.
  • the composition further includes a coating having a delayed release material selected from the group consisting of gum arabic, gelatin, ethylcellulose, hydroxypropyl methylcellulose and combinations thereof.
  • the functional ingredient comprises a hydrophilic material in a matrix.
  • the composition further includes an intermediate coating between the enteric material coating and the outer coating, the interior coating comprising ethylcellulose.
  • the functional ingredient composition includes a hydrophobic material which is entrapped within a matrix of an enteric material selected from shellac, caseinate, zein, and combinations thereof.
  • the functional ingredient comprises essential oils.
  • the outer coating is selected from the group consisting of methyl methacrylate, N,N-dimethylaminoethylmethacrylate, cross-linked chitosan, poly (2- vinylpyridine-co-styrene) and combinations thereof.
  • the microencapsulated composition includes particles having a size in the range of about 75 to about 500 ⁇ .
  • the microencapsulated composition includes particles having a density of about 1.0 to about 2.0 g/ cc.
  • FIG. 1 is a diagrammatic representation of an enteric material including a core and a plurality of optional coatings
  • FIG. 2 is a diagrammatic representation of an enteric material having a plurality of microcapsules within a core
  • FIG. 3 is a diagrammatic representation of an enteric material infused within a feed material
  • FIG. 4 is a diagrammatic representation of an enteric material comprising a plurality of microcapsules infused within a feed material;
  • FIG. 5 is a process flow diagram for one form for preparing a microencapsulated composition.
  • FIG. 6 is an illustration of samples particles subjected to simulated ruminant digestion.
  • a microencapsulated composition including a functional ingredient and a method for manufacture.
  • the composition includes one or more enteric materials as well as one or more coatings that can be used in combination to delay the release of the functional ingredient prior to a desired dissolution location, such as in the intestine.
  • a desired dissolution location such as in the intestine.
  • Such a combination of features may be suitable for animals and/or in animal feed, functional feed and the like, and are particularly suited for ruminant digestion.
  • “functional feed” generally encompasses any type of feed that incorporates a functional ingredient to be delivered to the human and/ or animal.
  • Functional feed can be used to decrease and/ or eliminate the need to handle the animals, such as by forcing the animals to ingest or otherwise receive the functional ingredients. Such a delivery can help where the functional ingredient is large or has an undesirable taste. If the person or animal is unwilling to ingest the functional ingredient, delivery can be problematic. Therefore, by incorporating the functional ingredient in a functional feed, the functional ingredient can be made more appetizing.
  • the microencapsulated composition may include encapsulated materials, as well as encapsulated materials in the form of a matrix.
  • matrix refers to a type of encapsulation that is somewhat different from traditional core and shell encapsulation which has a single functional material coated by the encapsulating material.
  • Matrix encapsulation is generally directed to a three dimensional material, which may be spherical, semi-spherical and the like (or other shapes), with multiple active particulates, liquids and/ or solids distributed and/ or embedded throughout the matrix particle.
  • the matrix includes a plurality of oil droplets dispersed throughout the matrix material.
  • the matrix particle may include a plurality of oil droplets dispersed in the matrix material.
  • the matrix may stabilize and/ or protect the functional ingredients within.
  • the matrix particle may then be further encapsulated with one or more coatings.
  • FIG. 1 one form of a microencapsulated material 10 is shown.
  • the microencapsulated material 10 includes a core 12, a first coating 14 and a second coating 16 effective to provide enteric delivery to animals and, in particular, ruminants. While two coatings or layers are shown, the microencapsulated material 10 may include any number of coatings effective for providing a composition which is suitable for animals and/ or in animal feed, and particularly ruminant digestion. Further, it should be noted that the microencapsulated material 10 may take a variety of shapes, including irregular shapes.
  • the core 12 generally may include a number of different components, such as a functional ingredient, a non-active carrier, one or more enteric materials and the like in a matrix.
  • the selection of materials for the core 12 may be such that the core 12, by itself, has enteric properties and, in addition, may also be coated with one or more optional enteric coatings as shown in FIG. 1.
  • the core 12 does not have enteric properties by itself, but may be coated by one or more optional enteric coating(s).
  • the core 12 may include functional ingredients such as essential oils, non-active carriers such as lipids, and enteric materials forming the matrix such as soy protein, sodium caseinate, shellac, zein, hydroxypropyl methylcellulose, and combinations thereof, to suggest a few enteric materials.
  • functional ingredients such as essential oils, non-active carriers such as lipids, and enteric materials forming the matrix such as soy protein, sodium caseinate, shellac, zein, hydroxypropyl methylcellulose, and combinations thereof, to suggest a few enteric materials.
  • the core includes about 1 to about 90 wt.% of enteric materials and about 40 to about 95 wt.% of functional ingredients, both on a dry weight basis of the core ingredients.
  • the core includes about 15 to about 35 wt.% of enteric materials and about 65 to about 85 wt.% of functional ingredients, both on a dry weight basis of the core ingredients.
  • the core includes about 10 to about 60 wt.% enteric materials and in other forms about 20 to about 60 wt.% enteric materials.
  • the core includes about 10 to about 70 wt.% enteric materials.
  • the core includes about 20 to about 60 wt.% of each of the soy protein and sodium caseinate.
  • the enteric matrix is zein, shellac, and mixtures thereof.
  • the core 12 may include hydrophobic materials, hydrophilic material, hydrophobic/hydrophilic materials and the like. Further, the core may include
  • the core 12 may include omega-3 oils, probiotics, polyphenols, anti-parasitic materials, vaccines, antibiotics, essential oils, micro-nutrients such as amino acids, fatty acids, minerals, and the like.
  • the hydrophilic material may be entrapped in the core 12 such as via spray drying.
  • the hydrophilic actives can be entrapped in a slow release hydrophilic polymer via spray drying.
  • hydrophilic functional ingredients can be combined with hydroxypropyl methylcellulose (HPMC) and then spray dried to form a HPMC-type matrix entrapping the hydrophilic ingredients.
  • HPMC hydroxypropyl methylcellulose
  • Other polymers can also be used.
  • the spray dried materials can also be granulated to achieve a desirable size for later coating. In some cases, the particles may be granulated to sizes greater than about 100 ⁇ .
  • the hydrophilic actives can be entrapped in an enteric type polymer by hydrating/ dispersing the hydrophilic material in an enteric polymer solution which can then either be spray dried or spray fluid dried to contain the functional material distributed within an enteric matrix.
  • the hydrophobic materials may be emulsified with one or more enteric materials to form a matrix.
  • the hydrophobic active can be emulsified with zein, shellac, sodium caseinate, soy and the like and then acid titrated to form the core 12 defining a matrix of zein, shellac, sodium caseinate, soy, and the like enteric materials.
  • the matrix may be formed by methods as described in U.S. Patent Publication No. 2010/0310726, which is incorporated by reference herein in its entirety.
  • the hydrophobic material may be emulsified/ dispersed in a binary solvent, such as a combination of water and alcohol, such that the solvent may be later removed via spray drying or other methods to entrap the functional material within an enteric matrix.
  • a binary solvent such as a combination of water and alcohol
  • the core 12 may include enteric materials such as zein and shellac and may also include other materials to accommodate the hydrophobic and/ or hydrophilic nature of the functional ingredients in the core 12.
  • the core 12 may take a variety of forms, including, but not limited to core capsules, a matrix and the like.
  • the composition may be composed of core capsules containing proteins such as sodium caseinate and soy prepared at and/ or below their isoelectric point to maintain enteric properties.
  • the core microcapsules 12 may then be coated with a unique combination of food grade, enteric polymers to provide one or more coatings or layers suitable for animal digestion and, in some cases, ruminant digestion.
  • the first coating is prepared from a binary solvent (alcohol/ water) based zein and/or shellac solution
  • the second coating which in some cases may be the outermost coating, is also prepared from a material that provides delayed release in ruminant animals. It is believed that the combination of the two coatings with the core materials may be used to provide delayed enteric release in animals, including ruminant animals that have pH requirements (6-8) and digestion times (up to 20 hours) prior to stomach and intestinal digestion, much different than humans.
  • the first coating 14 may include a variety of different materials, including, but not limited, to enteric materials.
  • the first coating 14 includes at least one of zein, shellac, in combination with modified cellulose polymers such as ethylcellulose and hydroxypropyl methylcellulose.
  • the first coating 14 includes an alcohol-based zein (which generally refers to a binary solvent of alcohol and water).
  • the first coating 14 may be provided in a variety of amounts and thicknesses as desired.
  • the first coating 14 includes about 1 to about 80 wt.% zein and/ or shellac on a dry basis relative to the total composition.
  • the first coating 14 includes about 5 to about 80 wt.% zein and/ or shellac. In another form, the first coating 14 includes about 10 to about 60 wt.% zein and/ or shellac on a dry basis relative to the total microencapsulated material 10. It should be noted that other materials may be included in the first coating 14 as will be described below in more detail.
  • Zein may be used as the first coating, which in an inner coating that is otherwise protected by the second coating such as a coating of ethylcellulose in one approach.
  • the zein may be used to provide a more controlled enteric release of the functional ingredient at the desired pH when ingested by the user.
  • the second or outer coating 16 may be a rumen protective coating and may also include a variety of different materials, including, but not limited to materials which provide for delayed release in ruminant animals.
  • the second or outer coating may be any coating that is stable or resistant to pH values greater than about 6, but is soluble beyond the rumen pouch and dissolves at a stomach pH of less than about 5.5, and is also stable to
  • the second coating 14 includes polycationic polymers such as methyl methacrylate and N,N-dimethylaminoethylmethacrylate (DMAEM). These polymers have minimal solubility at or above about pH 5.5 and higher solubility at stomach pH, which is generally less than about 5.5.
  • DMAEM N,N-dimethylaminoethylmethacrylate
  • the coating may also include cross-linked chitosan and combinations of chitosan with other materials.
  • the cross-linked chitosan may be cross-linked with gluteraldehyde.
  • the second coating 16 may be provided in a variety of amounts and thicknesses as desired.
  • the composition includes about 1 to about 70 wt.% of the second coating on a dry weight basis of the total composition.
  • the composition includes about 10 to about 70 wt.% of the second coating.
  • the second coating 16 is provided such that the second coating 16 is included in an amount of about 10 to about 50 wt.% relative to the microencapsulated material.
  • the second coating may also include plasticizers.
  • the second coating includes about 1 to about 50 wt.% zein on a dry weight basis of the total composition.
  • the second coating includes shellac in an amount of about 1 to about 50 wt.% relative to the microencapsulated material.
  • the second or outer coating may be or include a high melting fat, such that it has a melting point of at least about 40°C or other body temperature of the ingesting entity that is water impermeable in the rumen and configured to dissolve or release in the intestinal tract due to lipase. Further, in one form, for better wettability, it may be preferable to add the high melting point fat prior to adding a polycationic layer. It should be noted that other materials may be included in the second coating 16 as will be described below in more detail. In one form, the second coating has solubility of less than about 20% at a pH greater than about 5.5. In some cases, the second coating has a solubility of about 10 to about 20% at a pH greater than about 5.5. It should be noted that other coatings, such as for providing protection in the rumen, may be included such as poly (2-vinylpy ridine-co-styrene) .
  • the composition may also include a variety of additional coatings.
  • the composition may include a plurality of different enteric materials.
  • the composition may also include optional intermediate coatings, such as water barrier type polymer materials.
  • One example may be to use ethylcellulose to provide further delayed release. This intermediate coating may be a water barrier.
  • the microencapsulated material 10 has a density of about 0.7 to about 2 g/ cc. In another form, the microencapsulated material 10 has a density of about 1.0 to about 1.5 g/cc. In some forms, it may be desirable to have a density of greater than about 1.0 g/ cc in view of lower density particles being regurgitated and re-masticated in ruminants. In other forms, the material 10 may have a density of about 0.8 to 2 g/cc, and in other forms, about 1.2 to about 1.4 g/ cc. Additional densifying materials such as iron oxide, weighting agents, elemental iron, and mixtures thereof, may be added to increase the density.
  • Densities may aid in achieving target release of the actives in certain animals, such as ruminants.
  • the densities above help aid in eliminating buoyancy of the microencapsulated material 10 such that it will sink in the ruminant fluid and not be regurgitated with boluses of non-digested material for re-mastication.
  • denser particles may also shorten the transit time to the intestines. In some approaches, densities of about 1 to about 1.5 g/ cc may be effective to sink in the ruminant fluid.
  • the individual microencapsulated material or particle 10 has a particle size of about 75 to about 1000 microns, and more particularly, about 100 to about 500 microns. In other approaches, about 75 to about 500 microns, and in yet other approaches, about 100 to about 300 microns.
  • the microencapsulated material has a particle size of about 100 to about 300 microns.
  • particle sizes above may help aid in the microencapsulated material 10 from not being ground in the animal's mouth during mastication, and in the case of ruminants, re-mastication and the repetitive chewing process.
  • an average particle size of an particles which may be individual particles or agglomerated particles, may be about 1 to about 2 mm, in some cases, less than 1mm, to aid in the reduction and prevention of damage to the particle during mastication.
  • FIG. 2 Another form of microencapsulated material is provided in FIG. 2.
  • a microencapsulated material or granulated microcapsule 20 is provided having a plurality of microcapsules 22 contained in a core and/ or granulating material 26.
  • the microcapsules 22 can include a plurality of microencapsulated materials 10 as described above in FIG. 1.
  • the microcapsules 22 can include one or more enteric coatings, can include enteric matrix forms and include other features as described above with respect to FIG. 1.
  • FIG. 2 illustrates the microcapsules 22 spread out or uniformly distributed in the core 24, it should be understood that the core 24 may be packed with microcapsules 22 such that the microcapsules 22 are generally contacting one another.
  • the core 24 may include a granulating material 26 to assist in forming the core 24.
  • the granulating material 26 may help the microcapsules to agglomerate together.
  • Suitable granulating material includes carbohydrates such as maltodextrin, corn syrup solids, sugars, mono, di and oligosaccharides, silica, hydroxypropyl methylcellulose, starch, proteins, and mixtures thereof. Zein and/ or shellac may also be used as granulating material.
  • the granulating material may be provided to agglomerate the microcapsules into robust, larger particles having multiple microcapsules.
  • the formed granules may be strong and robust to withstand further processing handling and/ or mastication.
  • the granulating material may be provided in a variety of ranges, such as from about 1 to about 50% of the overall composition (in some approaches, about 5 to about 50% and other approaches about 1 to about 20%).
  • the particle 20 may be formed by a granulation
  • the core 24 may also include any number of different coatings, similar to the discussion regarding FIG. 1.
  • the core 24 may include enteric coatings and other coatings for delaying release of the core materials when chewed and digested in animals, including ruminant animals.
  • the core 24 may include an outer coating 28 similar to second coating 16 in FIG. 1.
  • the outer coating 28 may include methyl methacrylate, N,N-dimethylaminoethylmethacrylate, cross-linked chitosan and combinations thereof.
  • Other materials such as poly (2-vinylpyridine-co-styrene) may also be used.
  • the microencapsulated material 20 has a density of about 0.8 to about 2.0 g/ cc. In another form, the microencapsulated material 20 has a density of about 1.0 to about 1.5 g/cc and in other forms about 1.2 to about 1.5 g/ cc. Additional materials such as iron oxide may be added to the granulating material 26, the microcapsules 22, and/ or the various coatings to increase the density. According to one form, the microencapsulated material 20 has a particle size of about 5 microns to about 6 mm (in some approaches up to about 1 mm) and more particularly about 100 microns to about 3 mm and in other forms about 100 microns to about 300 microns.
  • FIG. 3 a further embodiment of an enteric material is shown. As seen in FIG. 3, an animal feed composition 30 is shown. The composition is
  • the animal feed composition 30 includes feed material 32, such as grain, cereal, corn, soy beans, wheat, rice, and the like, and mixtures thereof, that is combined with actives or functional ingredients and protective enteric coatings and encapsulation.
  • the feed 32 material may be dehulled, whole, half, grit and meal.
  • the feed material 32 also includes actives or functional ingredients (not shown) which have been incorporated with or into the interior of the feed material 32.
  • the functional ingredients can be incorporated such as by infusing the functional ingredients into the feed material 32 as will be described in more detail below.
  • the animal feed 30 also includes an enteric coating 34, such as using materials described above in FIG. 1 for layer 14.
  • the enteric coating 34 may include zein, shellac, ethylcellulose and other enteric polymers.
  • the thickness of the enteric coating 34 will be selected to provide the desired target release in the animal tract, and can vary for transit time of the animal. In one approach, the thickness of layer 34 may be about 1 to about 100 microns.
  • the animal feed 30 may also include other layers, such as a second or outer coating 36, that can be used to provide protection against release in ruminant animals and may be any of the materials and include any of the characteristics of layer 16 described above.
  • the second coating 36 can include methyl methacrylate, N, N- dimethylaminoethylmethacrylate (DMAEM) and cross-linked chitosan.
  • the second or outer coatings may also be or include a high melting point fat coating that may be water impermeable in the rumen and then provides release characteristics in the intestinal tract due to lipase action. Due to wettability, it is preferred as a middle coat.
  • the feed 30 may also include an optional middle or intermediate coating similar to that described with particle 10 above.
  • the animal feed 30 may be prepared by, first, infusing the grain with the actives or functional ingredients and, second, applying the various coatings and protectants described above. More specifically, the process may first optionally swell the grain material 32 with cold or hot water and then infuse the feed material 32 with the functional ingredient and any other materials that are desired on the interior of the feed material 32.
  • the functional ingredient in the case of hydrophilic functional ingredients, can be combined with water and then infused into the feed material 32.
  • the functional ingredient can be emulsified and then infused into the feed material 32.
  • pre-emulsification in water is generally used in some approaches to achieve submicron size oil droplets.
  • sugars and salts can be used to help increase the infusion rate.
  • An organic solvent such as ethanol or ethanol/ water blend can be utilized as a carrier for the hydrophobic actives such as essential oils discussed below.
  • the infusion solution can also include a protective polymer/ film former for better infusion rate and have a low solution viscosity to help achieve good infusion.
  • the grain is pre-treated to increase the micropores and therefore facilitate higher infusion rates and volumes.
  • the feed material 32 is dried to entrap the functional ingredient therein and provide shelf stability to the feed material 32.
  • the coatings (such as, layers 34 and 36) may then be applied such as using a fluid bed coating for small feed material and pan coating for larger feed materials. Any number of different coatings may be applied to provide desired release characteristics, as described above.
  • FIG. 4 a variation on the embodiment of FIG. 3 is shown.
  • an animal feed 40 is shown having a feed material 42, similar to FIG. 3.
  • FIG. 4 incorporates the functional ingredient in the feed material 42 in the form of microcapsules 44, similar to the embodiment of FIG. 2.
  • the microcapsules 44 may be in the form of functional ingredients combined with an enteric material which results in the microcapsules 44.
  • the feed material may then be dried and then coated, such as with coatings 48 and 50 similar to the coatings and protectants described above with FIG. 3.
  • Coatings 48 and 50 can include further enteric coatings and coatings suitable for ruminant animals.
  • the functional ingredient for the embodiments described above can include any mixture of hydrophobic liquids and solids, such as solids mixed or combined therewith or dissolved or solubilized therein.
  • functional ingredients can be selected to include materials which are desired to be released in the small intestine rather than the stomach due to pH sensitivity.
  • the functional ingredient can include compositions described in U.S. Patent Publication No. 2008/0145462 to Enan or include esterified forms of such compositions.
  • the functional ingredient includes about 25 to about 35% by weight para-cymene, about 1 to about 10% by weight linalool, about 1 to about 10% by weight alpha-pinene, about 35 to about 45% by weight thymol, and about 20 to about 30% by weight soybean oil.
  • the functional ingredient described herein can include an essential oil blend which possesses anti-parasitic properties.
  • the essential oil blend is organic compounds blended with food grade oil, i.e., soybean oil.
  • the organic compounds can include thymol and linalool.
  • the organic compounds include alpha-pinene and para-cymene.
  • One exemplary blend of an essential oil includes, by weight, about 17.5 percent soybean oil, about 8 percent alpha-pinene (liquid), about 44 percent para-cymene (liquid), about 5 percent linalool (liquid) and about
  • the functional ingredient may also include modified forms of the hydrophobic liquid, as described in provisional Patent Application Serial No. 61 / 422,439, filed December 13, 2010, which is incorporated herein in its entirety by reference.
  • the hydrophobic liquid includes esters, such as esters of linalool and thymol, as described in Application Serial No. 12/479,444, filed June 5, 2009, which is incorporated herein in its entirety by reference.
  • Another exemplary form includes about 10 wt.% para-cymene, 5 wt.% alpha-pinene, 15 wt.% linalyl acetate, and about 70 wt.% thymyl octanoate.
  • the functional ingredient can include a portion that is modified, such as by esterification, and can comprise from about 1 to about 99 percent of the functional ingredient by weight.
  • the modified functional ingredient can include from at least about 10 percent of the functional ingredient by weight and, in other approaches, about 30 percent by weight.
  • the modified functional ingredient can include from about 25 to about 65 percent of the functional ingredient by weight.
  • the blend of non-active carrier and functional ingredient can include, by weight, about 15 to about 30 percent canola oil, about 1 to about 10 percent alpha pinene, about 5 to about 25 percent para-cymene, about 5 to about 20 percent linalyl ester and about 20 to about 60 percent thymyl ester.
  • the blend of non-active carrier and functional ingredient can include, by weight, about 20 to about 25 percent canola oil, about 2 to about 7 percent alpha pinene, about 10 to about 20 percent para-cymene, about 7 to about 15 percent linalyl ester and about 35 to about 50 percent thymyl ester.
  • the selected esterified form of the functional ingredient may have increased functionality due to an increased rate of hydrolysis over the parent form after ingestion and release from the enteric matrix in an intestinal tract.
  • Esters may be obtained from natural sources or synthesized using any suitable chemical or biochemical reactions between functional ingredients, such as thymol and linalool, and organic or inorganic oxoacids that yield esters.
  • Suitable oxoacids may include carboxylic acid, amino acids, phosphoric acid, sulfuric acid, and nitric acid.
  • the hydroxyl group can be derived from a homogenous source (e.g., thymol) or mixed source (thymol and linalool).
  • Exemplary monocarboxylic acids include, but are not limited to, acetic, propionic, butyric, pentanoic, hexanoic, octanoic, decanoic, stearic, lactic, cinnamic, pyruvic, benzoic, and gluconic acids.
  • Exemplary dicarboxylic acids include, but are not limited to, oxalic, malonic, maleic, fumaric, tartaric, succinic, glutaric, glucaric, adipic, pimelic, suberic, azelaic, and sebacic acids.
  • Exemplary tricarboxylic acids include, but are not limited to, citric and isocitric acids.
  • Other exemplary esters that may be formed by reactions of terpenes with oxoacids include dithymol succinate, dithymol adipate, and dithymol sebacate.
  • the modified functional ingredient can include an ester formed, regardless of chemical or biochemical reaction approach for its preparation, between terpene esters and other esters.
  • the functional group can be formed using transesteri- fication.
  • the functional group can include an ester formed by reacting thymol acetate with methyl octanoate or tripalmitin.
  • the functional ingredient can include other modified compounds.
  • the modified functional group can include any glycoside formed by chemical or biochemical reaction between the hydroxyl group(s) of a terpene and a single sugar group (monosaccharide) or several sugar groups (oligosaccharide).
  • a single sugar group monosaccharide
  • oligosaccharide oligosaccharide
  • thymol and/ or linalool glycosides can be the modified functional ingredient.
  • the sugar group can include any glycoside with the glycone portion composed of mono, di, tri, and/ or polysaccharides of any kind and the aglycone portion being any hydroxy-terpene (e.g., thymol, linalool).
  • the sugar group can also include reducing sugars and/ or non- reducing sugars.
  • Exemplary sugars include, but are not limited to, glucose, fructose, galactose, ribose, sucrose, mannose, maltose, lactose, and cellobiose.
  • the functional group can include any ionic or nonionic salt or complex formed involving a hydroxy-terpene and another chemical species.
  • thymol and linalool salts or complexes can be the modified functional ingredient.
  • One example may be sodium and/ or potassium salts.
  • the modified functional ingredient may include thymol salts that do not have fixed
  • thymol salts may be prepared as partial or mixed salts having different ratios of cations and thymol comprising one or more specific cations (Na+, K+, Mg++, etc.) to prepare solid complexes.
  • the solidified complexes may or may not be obtained in crystalline form.
  • the salt or complex may be formed by any suitable method, but in some cases is formed by a chemical reaction or association between one or more hydroxy-terpene and one or more alkaline reagent.
  • Exemplary alkaline reagents may include, but are not limited to, alkaline hydroxide, oxide, bicarbonate, or carbonate.
  • the salt or complex can include any alkali metal, alkaline earth metal, or transition metal element, or combination thereof.
  • Suitable salts or complex for use in foods may include those formed from sodium, potassium, lithium, calcium, magnesium, iron, manganese, zinc, and aluminum.
  • Other exemplary salts include any mono, di, or trivalent salt of thymol, including sodium thymolate (e.g., sodium thymoxide) and any mono, di, or trivalent salt of phenol, including calcium phenoxide.
  • the functional ingredient may include various forms of modification that are combined.
  • a portion of the modified functional ingredient composition may include one or more of salts, glycosides, complexes and esterified forms of one or more essential oils.
  • Modifications to the functional ingredient may include a variety of forms that modify the perceived taste and/ or organoleptic properties of the functional ingredient.
  • the modification may cause a change to the flavor and/ or taste threshold of the functional ingredient.
  • the modification causes a change to the volatility and/ or vapor pressure of the modified functional ingredient with respect to the non-modified, parent form of the functional ingredient.
  • the organoleptic properties of the modified form may include a higher taste threshold.
  • the modifications may include salt, glycoside, complex and/ or esterification of the functional ingredient.
  • the modified form of the functional ingredient When ingested and released in the intestinal tract, the modified form of the functional ingredient reverts back, at least in part, into the parent form and provides the same functional benefits as if the parent functional ingredient was microencapsulated and consumed.
  • the modified functional ingredient hydrolyzes from the modified form back into the parent, non-modified form of the functional ingredient during digestion.
  • the functional ingredient described herein can include compounds which possess functional properties, such as anti-parasitic, anti-protozoan, and anti-fungal.
  • the organic compounds further include alpha-pinene and para-cymene.
  • Suitable examples of a materials which may be included in the core include unsaturated and polyunsaturated OMEGA 3, other unsaturated and
  • an ester may have higher microencapsulation efficiency, such as described above, than non-esterified parent compounds, such as thymol and linalool.
  • the efficiency increases about 50 to about 200 percent over the efficiency observed when using non-esterified functional ingredients, more preferably about 100 to about 150 percent.
  • esters have a higher olfactory perception threshold than the parent compounds, such that amount of esters necessary to be perceived is more than the amount of non-esterified thymol and linalool.
  • FIG. 5 One method for microencapsulating a functional ingredient, such as a hydrophobic material, is generally described in FIG. 5.
  • a functional ingredient such as a hydrophobic material
  • FIG. 5 water, an enteric material and optionally an emulsif ier are subjected to agitation until the enteric material and emulsifier are combined with the water to form a solution, such as at step 120.
  • the emulsifier and enteric material can be added to the water together or separately, with either being added first.
  • the pH of the solution is generally greater than about 7, and generally greater than about 7.1 to about 9.
  • a base such as sodium, ammonium or potassium hydroxide, carbonates, bicarbonates and combinations thereof, can be added to the solution to maintain the pH greater than about 7, and in yet other cases from greater than about 7 to about 9 to maintain dissolution of the enteric polymers in water substantially free of organic solvents.
  • the functional ingredient is then added to the enteric material solution, such as at step 130.
  • the enteric material solution containing the functional ingredient is then mixed, such as at step 140.
  • the materials are agitated or mixed to form an emulsion.
  • “agitation” or “agitated” generally refers to the use of a top mixer with impeller or a rotor/ stator mixing device operating at a speed of less than about 10,000 RPM. Other mixing devices may also be employed.
  • the materials are then acid titrated to precipitate out the functional ingredient microencapsulated with the enteric material, such as at step 150, in a matrix core structure that is generally tiny droplets of functional ingredients substantially
  • the material is titrated with acid in an amount effective to decrease the pH below the isoelectric or solubility point of the enteric materials causing phase separation and inducing precipitation of the enteric material out of solution with the functional ingredient being microencapsulated therein, thus creating a slurry of an aqueous solution and precipitate.
  • the slurry includes a particulate precipitate having a particle size from about 1 to about 1000 micrometers, in some cases about 10 to about 500 micrometers, and in yet other cases from about 75 to about 250 micrometers.
  • precipitation occurs at a pH ranging from about 3 to about 6.5, and in other approaches from about 3 to about 5, and in one approach at a pH of about 4.5.
  • a fine, stable emulsion of sodium caseinate and soy protein may be titrated with an acid to a pH corresponding to the insolubility at the isoelectric point of sodium caseinate, such as about 4.4 to about 4.6.
  • the slurry may be allowed to settle, resulting in a clear division of the liquid or supernatant and the settled particulate.
  • enteric materials such as soy protein and sodium caseinate may cross-link to like particles or to one another to form a matrix, the hydrophobic liquid being microencapsulated within the matrix.
  • the functional ingredient is homogeneously dispersed throughout the matrix.
  • the matrix further provides a seal for the functional ingredient.
  • the acid used for step 150 can be any acid, including, but not limited to, food grade acid.
  • the acid is a weak food grade acid.
  • the acid may be citric acid.
  • the composition of the enteric material affects the dissolution rate and the protection provided by the enteric matrix. As a result, the rate and amount of acid addition varies based on the enteric matrix materials used.
  • the slurry may be optionally filtered to produce a wet cake, then washed and dried to produce a dried cake.
  • the particulate and the supernatant are both filtered to produce a cake, then washed and dried to provide a dried cake.
  • the slurry or supernatant and particulate are filtered to provide a wet cake. The wet cake is then washed, refiltered and rewashed prior to drying.
  • the surface oil on the outer surface of the particulate precipitate is less than about 1 percent by weight of the final product.
  • a surface oil remover may be added to aid in removing residual surface oil from the precipitate, as described in co-pending Application Serial No. 12/ 479,433, filed June 5, 2009, which is incorporated herein in its entirety by reference. Further, the surface oil remover can also be added at any point in the preparation after acid titrating.
  • the first coating is applied to the microencapsulated functional ingredient, as shown in step 160.
  • a second coating may be applied, such as shown in step 170.
  • additional coatings may be included beyond the first and second coatings.
  • the coatings may include a small amount of a suitable plasticizer, such as one that is soluble/ miscible in water.
  • each solution to prepare the first and second outer coatings can include about 5 percent to about 20 percent enteric material and about 1 percent to about 3 percent plasticizer including, but not limited to, glycerin and other suitable plasticizers.
  • the final, coated microencapsulated particles can include between about 1 to about 15 percent by weight of each of the first and second coatings.
  • the coating materials can be applied to the enteric matrix by mixing, spraying or other suitable application.
  • the coating materials are first solubilized in water.
  • a base can optionally be added to the solubilized outer coating material to increase the pH to greater than about 7, in some cases between about 7.1 and about 12.
  • the solubilized material can then be atomized and sprayed onto the uncoated particulate product.
  • the first and second coatings each have coating thicknesses of about 1 micrometer to about 5 micrometers. If desired, the coated matrix particles can then be sieved to meet the desired particle size.
  • the thickness of the first coating 14, 34, or 48 tends to provide the desired target release in the intestinal tract. In some cases, the thickness can be varied based on transit time in the animal. For instance, for a ruminant with a rumination transit time of 15-20 hours, the thickness of the first coating will be at the high end of the range such as about 4 to about 5 micrometers. The thickness may be modified to accommodate different transit times, animal sizes and the like. In some cases, the thickness may be up to about 10 microns or even higher depending on the circumstances.
  • Additional processing steps after the second coating may also be included.
  • steps may include drying and/ or otherwise removing moisture from the coated microcapsules to form a material having less than about 10%, and, in some forms, less than 5% moisture.
  • the coating materials are applied by spraying a fine mist of the respective coating onto fluidized core capsules to create uniformly coated particles.
  • a fine mist of the respective coating onto fluidized core capsules to create uniformly coated particles.
  • Such a process can include top and/ or bottom spraying. In one form, such a process can combine simultaneous layer coating with instant drying.
  • pan coating may be more suitable in view of the size and/ or density which may limit the air fluidization of such particles.
  • the particles are tumbled in a rotating drum with baffles while the coating is atomized and sprayed on the particles. In this form, spraying and drying may be carried out simultaneously.
  • steps may also be included, such as grinding the dried material to form a powder.
  • steps may include, but are not limited to, washing the microencapsulated material to remove unencapsulated functional ingredients, pH adjustments and the like.
  • the powder can be pulverized to reduce the particle size of the powder precipitate, and then further dried to a moisture content of less than about 5 percent, such as with a fluidized bed dryer.
  • the resultant particles have a particle size ranging from about 1 to about 1000 micrometers, in some approaches from about 10 to about 500 micrometers, and in other approaches from about 75 to about 250 micrometers.
  • the temperature may be maintained between about 25°C to about 70°C, in some approaches between about 35°C to about 60°C, and in other approaches between about 35°C and about 45°C.
  • the temperature may be maintained between about 4°C to about 40°C, in some cases about 4°C to about 30°C, and in other cases from about 15°C to about 28°C.
  • the core is substantially free of organic solvents.
  • substantially free of organic solvent generally refers to an amount of added organic solvent, such as isopropanol or ethanol or any other food-grade organic solvent, which is less than the amount of organic solvent required to enable solubilization of the enteric material under the processing conditions.
  • the amount of added organic solvent is less than about 0.1 percent by weight of the combination of water, emulsifier and enteric material.
  • organic solvent generally refers to a non-aqueous, hydrocarbon-based liquid.
  • the core and/ or coating may include organic solvents.
  • the enteric material used herein is any food grade enteric polymer, or a combination or two or more food grade enteric polymers.
  • the enteric material is a caseinate, such as sodium caseinate, soy protein or a combination thereof.
  • enteric materials that may be included in the core include shellac and zein.
  • the shellac can be provided as an alkaline (pH > 7) aqueous solution, such as a water-based solution having a solid content of about 25 percent by weight or it can be prepared from refined, bleached and dewaxed shellac powder.
  • the shellac is substantially free of organic solvent, although it may contain trace amounts of organic solvents, such as isopropyl alcohol (such as can be included in commercial products), to act as a carrier for other ingredients in the shellac solution, such as methyl and propyl parabens.
  • the prepared shellac solution does not contain any added organic solvents.
  • the enteric material consists essentially of soy protein and sodium caseinate. It should be noted that soy protein and sodium caseinate may not be thought of as traditional enteric materials. However, when the soy protein and sodium caseinate are prepared near their isoelectric points (about 4.4 to about 4.6 for soy protein and sodium caseinate), the materials take on enteric functionality such that they would be considered enteric materials.
  • the enteric matrix material and optional emulsifier may be solubilized in water, in one form alkaline water, substantially free of an organic solvent.
  • soy protein and sodium caseinate provides an emulsification capability so that the addition of an emulsifier is not required in this approach.
  • soy protein and sodium caseinate improves stability of the resulting microencapsulated functional ingredient over the duration of the shelf life of the microencapsulated functional ingredient.
  • the soy protein and sodium caseinate are solubilized separately in separate aqueous solutions and then combined in a single solution.
  • a desired ratio of soy protein to sodium caseinate ranges from about 1:60 to about 60:1 in other cases the ratio ranges from about 1:10 to about 10:1 and in yet other cases the ratio ranges from about 2:1 to about 1:2.
  • the emulsifier described herein is any food grade emulsifier.
  • the emulsifier is polysorbate, poly glycerol ester, sucrose stearate, sucrose esters, proteins, lecithins or combinations thereof.
  • the methods described herein combine water, an optional emulsifier, the enteric materials and the functional ingredient in a manner effective to microencapsulate the functional ingredient in the enteric materials.
  • the methods use water in amounts from about 50 percent to about 95 percent of the combination by weight and, in some approaches, from about 70 to about 95 percent, and, in other approaches, from about 80 to about 90 percent.
  • the optional emulsifier is generally less than about 5 percent of the combination by weight, in some instances from about 0.01 to about 1 percent by weight, and, in other instances, about 0.01 to about 0.1 percent by weight of the combination.
  • the enteric material ranges from about 3 percent to about 35 percent by weight, in some approaches from about 3 to about 23 percent, and, in other approaches, from about 10 percent to about 15 percent by weight of the combination.
  • the functional ingredient generally is in amounts of about 1 to about 15 percent by weight of the combination, and in other approaches, about 3 to about 6 percent by weight, as measured in a wet state prior to titration.
  • the microencapsulated hydrophobic liquid produced by the above described methods may have an increased payload.
  • Payload generally refers to the weight percentage of the functional ingredients in relation to the final particulate product.
  • the total payload generally refers to the total weight percentage of all the encapsulated functional ingredients, including any carrier oil, in relation to the final particulate product. Therefore, an increase in payload corresponds to an increase in functional ingredient per a given amount of enteric matrix.
  • a model system was developed to analyze the enteric delivery performance at various pH levels to determine if the combination of enteric and encapsulating materials would be suitable for targeted ruminant delivery of functional ingredients.
  • a composition was prepared having the components listed below in Table 1.
  • An annato/ medium chain triglyceride oil was used as a functional ingredient in this exemplary system as annatto oil was easy to evaluate for purposes of determining the performance in a targeted ruminant delivery system. It should be noted that other materials (such as the functional ingredients and essential oils previously discussed) would be expected to be incorporated in a similar manner and would be expected to have similar performance at the various pH levels tested.
  • the composition was prepared by hydrating the caseinate powder in water with overhead mixing for at least about 30 minutes. Next, shellac was added slowly while mixing to form the starting composition. About 120 g of Annato/ MCT (medium chain triglyceride) oil blend (about 2% Annate in MCT oil) was added to prepare a coarse emulsion. The coarse emulsion was homogenized through a two stage high pressure homogenizer at about 500/5000psi. Next, the emulsion was titrated with about 12% citric acid while continuously mixing to pH 4.5 to precipitate particulates and form slurry. The slurry was permitted to mix for about 5-10 minutes.
  • Annato/ MCT medium chain triglyceride
  • MCT oil blend about 2% Annate in MCT oil
  • the slurry had water removed by pressing at about 40 psi for about 30 minutes to make a filter cake.
  • the filter cake was then subjected to coarse grinding in food processor to form chunks.
  • the coarse ground cake is then extruded through an LCI extruder at about 90 rpm through a die with an about 1.2 mm to about 2.0 mm holes.
  • Strands of extrudates were collected and bench dried for about 48 hours.
  • the resulting material had a final moisture content of about 3.5%.
  • the dried material was milled and sifted to a desired particle size of about 1.2 mm to about 1.4 mm.
  • the dried material was then coated, which was carried out on two separate days. Three types of coating were applied: zein (inner coat), shellac (middle coat), and poly(2-Vinylpyridine-co-styrene) as an outer coat.
  • zein On the first day, zein was coated first, followed by shellac.
  • the zein coating composition was an alcohol based solution as found in Table 2 below.
  • the weight of the shellac coating solution used was about 104 g.
  • the coating conditions used were the same as those for zein and found in Table 3.
  • the coating solution was prepared by dispersing the polymer in alcohol and then adding acid. Deionized water was added about 20 minutes after mixing the alcohol polymer and acid. The combined composition was mixed until a clear solution formed, which was after about 1-2 hours. The weight of solution used for coating was about 480 g.
  • Example 1 The material prepared according to Example 1 was subjected to digestion testing over various pH levels for simulation of ruminant digestion. Two sets of material were prepared, each with three samples. The first set of material (Samples 1, 2 and 3) was coated and prepared according to Example 1. The second set of material (Samples 4, 5 and 6) was generally prepared in accordance with Example 1, but was not coated with the polymer coating. Generally, the first set of materials contained particles that were larger and more rounded as a result of the multiple coatings whereas the second set contained particles that were somewhat smaller.
  • Sample 1 which was coated in accordance with Example 1, contained particles that appeared substantially unchanged.
  • Sample 4 which was a sample that was not coated with polymer, was substantially dissolved into solution.
  • Samples 2, 3, 5 and 6 were further tested by adding concentrated HC1 to adjust the pH to about 2-3. Samples 2, 3, 5 and 6 were placed back in the shaking water bath at about 39°C for about 30 minutes. After shaking, Samples 2 and 5 were removed and centrifuged at about 6000 rpm for about 10 minutes. This treatment is a simulation of a second portion of a ruminant digestion, such as ruminant stomach contents.
  • Sample 2 contained particles that were smaller than the original size, but approximately the same size as the starting particles for the second set. Such a change in particle size for sample 2 is understandable as the outer polymer coating is believed to have been substantially removed such that the particles would be similar to the starting particles for the second set. Sample 5 appeared generally the same as Sample 4 as the particles had previously dissolved into solution in the first step.
  • Samples 3 and 6 were further tested by adding 0.5N NaOH to adjust the pH to about 7-8. These tubes were then placed back in the shaking water bath at about 39°C for about 18 hours. After shaking, the tubes were removed and centrifuge at about 6000 rpm for about 10 minutes. This treatment is a simulation of a third portion of ruminant digestion, such as ruminant small intestine contents. [00130] The particles in Sample 3 were substantially dissolved into solution. The particles in Sample 6 were also unchanged and remained dissolved into solution.
  • FIG. 6 An illustration of Samples 1, 2 and 3 during the various portions of the simulated ruminant digestion are shown in FIG. 6.
  • Samples 4, 5 and 6 were completely degraded during the first portion of the ruminant digestion and therefore are not shown in the figure.
  • Sample 1 which is shown after the simulation of the first portion of ruminant digestion includes relatively large particles that are substantially unchanged.
  • Sample 2 is shown after the simulation of the second portion of ruminant digestion where the particles are smaller than the particles in Sample 1 shown next to it (as evidenced by the reduced volume of the particles in Sample 2).
  • Sample 3 is shown after the third portion of ruminant digestion where the particles are degraded and otherwise in solution.
  • Samples 4, 5, and 6 were degraded after simulating the first portion of ruminant digestion, ruminant saliva and rumen contents (about pH of 8.2), since their outer coating is meant to be stable in acid but to degrade in alkaline
  • An animal feed composition may be prepared having one or more functional ingredients located on an interior of the feed material.
  • the feed material can be selected from a variety of different grains, cereals, legumes, wheat, soy, rice and the like, as well as combinations thereof.
  • An enteric coating covers at least one of the functional ingredient composition and the feed material. Further, the feed can include an outer coating having a solubility less than about 20% at a pH of about 5.5 or greater, the outer coating located on the exterior of the feed material.
  • the animal feed may be prepared by combining a feed material and a functional ingredient composition to infuse the functional ingredient composition into an interior of the feed material. Next, the feed material is dried to entrap the functional ingredient composition within the feed material, forming a dried feed material. The dried feed material can then be coated with at least one of an enteric coating and an outer coating having a solubility less than about 20% at a pH of about 5.5 or greater.
  • the enteric material is selected from the group consisting of zein, shellac and combinations thereof.
  • the animal feed may further include a coating having a delayed release material selected from the group consisting of gum arabic, gelatin, ethylcellulose, hydroxypropyl methylcellulose and combinations thereof.
  • the animal feed may further include an intermediate coating on the exterior of the feed material, the intermediate coating comprising ethylcellulose.
  • the animal feed may further include a water barrier coating selected from the group consisting of a lipid-type material, a high melting point fat, wax and combinations thereof.
  • the functional ingredient composition includes a hydrophobic material which is entrapped within a matrix of the enteric material.
  • the functional ingredient can include essential oils.
  • the outer coating can be selected from the group consisting of methyl methacrylate, N,N dimethylaminoethylmethacrylate, cross linked chitosan, and
  • the animal feed composition can include particles having a size in the range of about 75 to about 500 ⁇ .
  • the animal feed composition can include particles having a density of greater than about .0 g/ cc.
  • compositions and methods have been particularly described with specific reference to particular process and product embodiments, it will be appreciated that various alterations, modifications, and adaptations may be based on the present disclosure, and are intended to be within the spirit of this disclosure.
  • compositions described herein are particularly suited for ruminant animals.
  • the compositions can also be used with non-ruminant animals and, in some instances, will be free of the ruminant protective coating 16, 28, 36, and 50 in certain applications.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des matériaux microencapsulés et des procédés de fabrication qui peuvent convenir à des animaux, y compris à des animaux ruminants, tout en présentant des propriétés d'administration entérique pharmaceutiquement acceptables. Selon l'invention, des ingrédients fonctionnels, tels que des huiles essentielles, des produits pharmaceutiques, des vitamines, des minéraux et analogues sont microencapsulés dans une matrice entérique et/ou dans des microcapsules entériques. En outre, un enrobage constitué d'un matériau entérique est appliqué. Les matériaux microencapsulés sont également enrobés d'un enrobage qui présente une solubilité inférieure à environ 20 %, à un pH d'environ 5,5 ou plus. L'ingrédient fonctionnel peut également être infusé dans un matériau d'alimentation et enrobé pour être administré à un animal.
PCT/US2014/017656 2013-02-22 2014-02-21 Administration entérique d'ingrédients fonctionnels pour animaux WO2014130801A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361768091P 2013-02-22 2013-02-22
US61/768,091 2013-02-22

Publications (1)

Publication Number Publication Date
WO2014130801A1 true WO2014130801A1 (fr) 2014-08-28

Family

ID=50272741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/017656 WO2014130801A1 (fr) 2013-02-22 2014-02-21 Administration entérique d'ingrédients fonctionnels pour animaux

Country Status (1)

Country Link
WO (1) WO2014130801A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104522298A (zh) * 2014-12-31 2015-04-22 陈忆凤 包膜膨化饲料的加工方法
WO2017168426A1 (fr) * 2016-03-30 2017-10-05 Vital Beverages Global Inc. Compositions et procédés pour libération sélective dans le tractus gastro-intestinal
WO2021116396A1 (fr) * 2019-12-11 2021-06-17 Dsm Ip Assets B.V. Comprimées
WO2021116395A1 (fr) * 2019-12-11 2021-06-17 Dsm Ip Assets B.V. Nouvelle composition d'administration à libération lente

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2005537A (en) * 1977-09-02 1979-04-25 Eastman Kodak Co Preparing Medicinal or nutrient pellets for oral administration to ruminants
EP0351760A2 (fr) * 1988-07-19 1990-01-24 Mitsubishi Kasei Corporation Additif alimentaire destiné aus ruminants
AU614943B2 (en) * 1986-11-17 1991-09-19 Rhone-Poulenc Sante Composition for feeding ruminants containing a biologically active substance and its preparation
EP0610957A2 (fr) * 1993-02-12 1994-08-17 Ajinomoto Co., Inc. Procédé pour ajouter des acides aminés chez les ruminants
WO1999013869A1 (fr) * 1997-09-12 1999-03-25 Gerold Lukowski Formes medicamenteuses stables en milieu humide et resistant au suc gastrique, a l'usage des animaux

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2005537A (en) * 1977-09-02 1979-04-25 Eastman Kodak Co Preparing Medicinal or nutrient pellets for oral administration to ruminants
AU614943B2 (en) * 1986-11-17 1991-09-19 Rhone-Poulenc Sante Composition for feeding ruminants containing a biologically active substance and its preparation
EP0351760A2 (fr) * 1988-07-19 1990-01-24 Mitsubishi Kasei Corporation Additif alimentaire destiné aus ruminants
EP0610957A2 (fr) * 1993-02-12 1994-08-17 Ajinomoto Co., Inc. Procédé pour ajouter des acides aminés chez les ruminants
WO1999013869A1 (fr) * 1997-09-12 1999-03-25 Gerold Lukowski Formes medicamenteuses stables en milieu humide et resistant au suc gastrique, a l'usage des animaux

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104522298A (zh) * 2014-12-31 2015-04-22 陈忆凤 包膜膨化饲料的加工方法
WO2017168426A1 (fr) * 2016-03-30 2017-10-05 Vital Beverages Global Inc. Compositions et procédés pour libération sélective dans le tractus gastro-intestinal
JP2019513146A (ja) * 2016-03-30 2019-05-23 バイタル ビバレッジズ グローバル インコーポレーテッド 選択的ｇｉ管送達のための組成物および方法
WO2021116396A1 (fr) * 2019-12-11 2021-06-17 Dsm Ip Assets B.V. Comprimées
WO2021116395A1 (fr) * 2019-12-11 2021-06-17 Dsm Ip Assets B.V. Nouvelle composition d'administration à libération lente

Similar Documents

Publication Publication Date Title
US20190328670A1 (en) Microparticles for Oral Delivery
KR101994513B1 (ko) 개선된 쉘을 가지는 마이크로캡슐
EP2124905B1 (fr) Microcapsules comprenant de la proteine de pois
CN101574327B (zh) 密封的微胶囊凝聚体及其制备方法
EP1684733B1 (fr) Systemes gastro-intestinaux d'administration
US8034450B2 (en) Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
JP2006506410A (ja) 複数の殻を有するマイクロカプセル及びそれらの調製方法
CN101032683A (zh) 叶黄素微囊及其制备方法
WO2014130801A1 (fr) Administration entérique d'ingrédients fonctionnels pour animaux
JP2001017093A (ja) 油脂被覆組成物及びその製造方法
EP2490555A1 (fr) Composition de barrière
EP0923312A1 (fr) Composition pour administration orale presentant une haute efficacite d'absorption et procede de preparation de ladite composition
WO2008077401A1 (fr) Poudrage réactif
Contreras-López et al. Microencapsulation of Feed Additives with Potential in Livestock and Poultry Production: A Systematic Review
WO2010056957A1 (fr) Formulations alimentaires à libération contrôlée
NZ529015A (en) A rumen bypass composition containing a bioactive substance and a method for its preparation
AU2002247950A1 (en) A rumen bypass composition containing a bioactive substance and a method for its preparation
Julio et al. Development of delivery systems of bioactive compounds using chia seed by-products

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14709825

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14709825

Country of ref document: EP

Kind code of ref document: A1